<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Serum IgE and IgG responses to food antigens in normal and atopic dogs, and dogs with gastrointestinal disease
2
Serum IgE and IgG responses to food antigens in normal and atopic dogs, and dogs with gastrointestinal disease
3
Serum IgE Level in Chronic Lupoid Leishmaniasis
4
Serum IGF-I and hormonal responses to incremental exercise in athletes with and without left ventricular hypertrophy
5
Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours
6
Serum IGF-I and IGFBP-3 in healthy pregnancies and patients with preeclampsia
7
Serum IgG Level and IgG/IgM Ratio on Admission Predict Steroid-Resistant Response in Vietnamese Children with Idiopathic Nephrotic Syndrome
8
Serum IgM plays an important protective role in murine atherosclerosis
9
Serum IL-17 & eotaxin levels in asthmatic patients with allergic rhinitis
10
Serum IL-18 and hsCRP Correlate with Insulin Resistance without Effect of Calcitriol Treatment on Type 2 Diabetes
11
Serum immunoglobulin A, G and M in healthy adults in Dhofar, Oman
12
Serum immunoglobulin E and i mmunoglobulin G reactivity to Agaricus bisporus proteins in mushroom cultivation workers
13
Serum immunoglobulin G concentration in Southern elephant seal, Mirounga leonina (Linnaeus, 1758), from Elephant island (Antarctica): Sexual and adrenal steroid hormones effects
14
Serum immunoglobulin G concentration in Southern elephant seal, Mirounga leonina (Linnaeus, 1758), from Elephant island (Antarctica): Sexual and adrenal steroid hormones effects
15
Serum Immunoglobulin Levels in Splenectomized and Non-Splenectomized Patients with Major Beta-Thalassemia
16
Serum immunoglobulin M in Atlantic halibut (Hippoglossus hippoglossus): Characterisation of the molecule and its immunoreactivity
17
SERUM IMMUNOGLOBULINS and CRP LEVELS IN AUTISTIC CHILDREN
18
Serum Immunoglobulins, IL-1β, IL-2, and IFN-γ Gamma Level in Patients with Lymphedema Treated with Ortho-β-Hydroxy-Ethyl Rutosides (HR)
19
Serum Inflammation Biomarkers and Micronutrient Levels in Nigerian Breast Cancer Patients with Different Hormonal Immunohistochemistry Status
20
Serum Inflammatory Cytokines and Depression in Coronary Artery Disease
21
Serum inflammatory cytokines in patients with primary aldosteronism
22
Serum Inflammatory Markers in Dementia Disorders
23
Serum Inflammatory Markers in Osteoporotic Fracture Patients: A Survey in the Fracture Liaison Service at Shafayahyaeian Orthopedic Hospital, Tehran Province, Iran
24
Serum inflammatory markers in the elderly: are they useful in differentiating sepsis from SIRS?
25
Serum Inhibin B Concentration as a Prognostic Factor for Prediction of Sperm Retrieval in Testis Biopsy of Patients with Azoospermia
26
Serum inhibin concentrations in ovarian tumors
27
Serum Inhibition of Porphyromonas gingivalis Protease in the Dog, Cat and Sheep – A Preliminary Study
28
Serum Insulin and Glucose Levels and Breast Cancer Incidence: The Atherosclerosis Risk in Communities Study
29
Serum Insulin and Insulin Resistance in Patients with Acanthosis Nigricans
30
Serum Insulin Like Growth Factor-1 in Diabetic Patients with Macrovascular Complications
31
Serum insulin-like growth factor binding protein profiles in postmenopausal women: Their correlation with bone mineral density
32
Serum Insulin-Like Growth Factor-I and Tumor Size in Patients with Metastatic Liver Cancer
33
Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment
34
Serum Intact Parathyroid Hormone Level After Total Thyroidectomy or Total Thyroidectomy Plus Lymph Node Dissection for Thyroid Nodules: Report From 296 Surgical Cases
35
Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity
36
Serum interferon-alpha level in first degree relatives of systemic lupus erythematosus patients: Correlation with autoantibodies titers
37
Serum interferon-gamma-inducible protein 10 level was increased in myocardial infarction patients, and negatively correlated with infarct size
38
Serum Interleukin 13 Level in Steroid Sensitive Nephrotic Syndrome
39
Serum Interleukin 17 in Type 2 Diabetes Mellitus
40
Serum interleukin 27: a possible biomarker of pediatric systemic lupus erythematosus
41
Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection
42
Serum Interleukin 6 (IL -6) as Prognostic Marker in Egyptian CLL patients
43
Serum Interleukin 8 Concentrations in Obese Subjects With and Without Impaired Glucose Tolerance
44
Serum Interleukin 8 Level as a Diagnostic Marker in Late Neonatal Sepsis
45
Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma
46
Serum Interleukin-15 Concentration in Patients With Essential Hypertension
47
Serum Interleukin-17 Evaluation in Patients With Eosinophilic Gastrointestinal Disease
48
Serum interleukin-18 and extent of coronary artery disease in unstable angina
49
Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus
50
Serum interleukin-18 in children with steroid sensitive nephrotic syndrome
51
Serum Interleukin-23 Levels in Patients with Ulcerative Colitis
52
Serum Interleukin-24 Levels in Gastric and Breast Cancers and Non-cancerous Inflammations
53
Serum interleukin-6 (IL-6) and IL-10 concentrations in normal and septic neonatal foals
54
Serum interleukin-6 (IL-6) and IL-10 concentrations in normal and septic neonatal foals
55
Serum Interleukin-6 and Highly Sensitive C-Reactive Protein as Inflammatory Biomarkers in Atrial Fibrillation Patients
56
Serum Interleukin-6 as a Serologic Marker of Chronic Periapical Lesions: A Case-control Study
57
Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy
58
Serum Interleukin-6 Levels in Differential Diagnosis of Sepsis and Transient Tachypnea of Newborn
59
Serum Interleukin-6 Levels in the Differential Diagnosis of Sepsis and Transient Tachypnea of Newborn
60
Serum interleukin-8 levels may predict relapse in brucellosis
61
Serum interleukin-8, CA-125 levels, neutrophil-to-lymphocyte ratios, and combined markers in the diagnosis of endometriosis
62
Serum interleukins 6 and 8 in mild and severe asthmatic patients, is it difference?
63
Serum interleukins and urinary microglobulin in children with idiopathic nephrotic syndrome
64
Serum ionized magnesium and caicium and sex hormones in healthy young men: importance of serum progesterone level
65
Serum ionized magnesium and calcium in women after menopause: inverse relation of estrogen with ionized magnesium
66
Serum Ionized Magnesium: Comparison of Results Obtained with Three Ion-Selective Analyzers
67
Serum Ionized Magnesium: Relation to Blood Pressure and Racial Factors
68
Serum irisin levels as a potential marker for diagnosis of gestational diabetes mellitus
69
Serum irisin levels in metabolically healthy versus metabolically unhealthy obesity: A case-control study
70
Serum iron and ferritin levels in alopecia areata
71
Serum Iron and Free Hemoglobin Concentrations in Patients with Acute Ischemic Stroke
72
Serum iron in catatonia and neuroleptic malignant syndrome
73
Serum iron in catatonic and noncatatonic psychotic patients
74
Serum Iron Level, Coronary Artery Disease, and All-Cause Mortality in Older Men and Women
75
Serum iron level, ferritin and total iron binding capacity level among nonpregnant women with and without melasma
76
Serum Iron Markers in Patients With Chronic Hepatitis C Infection
77
Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults
78
Serum Ischemia-Modified Albumin, Fibrinogen, High Sensitivity C- Reactive Proteins in Type-2 Diabetes Mellitus without Hypertension and Diabetes Mellitus with Hypertension: A Case-Control Study
79
Serum KIM-1 and Cystatin Levels as the Predictors of Acute Kidney Injury in Asphyxiated Neonates
80
Serum Klotho Level and its Related Factors Among Male Opioids Addicts With Normal Renal Function Compared to Healthy Male Non-smokers and Smokers in Tabriz, Iran
81
Serum Klotho Levels in Trained Athletes
82
Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19 Lung Injury: A Systematic Review and Meta-Analysis
83
Serum lactate and base deficit as predictors of mortality and morbidity
84
Serum Lactate as a Predictor of Mortality in Emergency Department Patients with Infection
85
Serum Lactate as a Predictor of Mortality in Emergency Department Patients With Infection: Does the Lactate Level Tell the Whole Story?
86
Serum lactate as a prognostic factor in coronary artery bypass graft operation by on pump method
87
Serum lactate dehydrogenase level in childhood acute lymphoblastic leukemia
88
Serum lactate is a useful predictor of death in severe sepsis and septic shock
89
Serum Lactate Is not Correlated with Mixed or Central Venous Oxygen Saturation for Detecting Tissue Hypo Perfusion During Coronary Artery Bypass Graft Surgery: A Prospective Observational Study
90
Serum lactate, not base deficit, rapidly predicts survival after major burns
91
Serum Lactates Correlate With Mortality After Operations for Complex Congenital Heart Disease
92
Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value
93
Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis
94
Serum laminin assayed by Slot-Blot-ELISA in patients with combined viral hepatitis C and schistosomiasis
95
Serum L-carnitine levels and lipoprotein compositions in chronic viral hepatitis patients
96
SERUM LEAD LEVELS AND ITS HEMATOLOGICAL EFFECTS IN MALE CAR PAINTERS OF LAHORE
97
Serum Lectin-Like Oxidized-Low Density Lipoprotein Receptor-1 and Adiponectin Levels Are Associated With Coronary Artery Disease Accompanied With Metabolic Syndrome
98
Serum leptin and body composition in children with familial GH deficiency (GHD) due to a mutation in the growth hormone-releasing hormone (GHRH) receptor
99
SERUM LEPTIN AND CORTICOSTERONE LEVELS AFTER EXPOSURE TO NOISE STRESS IN RATS
100
Serum Leptin and Ghrelin Levels in Women with Polycystic Ovary Syndrome: Correlation with Anthropometric, Metabolic, and Endocrine Parameters
101
Serum leptin and its relationship with metabolic variables in Arabs with type 2 diabetes mellitus
102
Serum leptin as a determinant of bone resorption in healthy postmenopausal women
103
Serum Leptin as an Additional Possible Pathogenic Factor in Polycystic Ovary Syndrome
104
Serum Leptin Concentration, Adiposity, and Body Fat Distribution in Mexican-Americans
105
Serum leptin concentrations after surgery in young rats
106
Serum Leptin Concentrations during the Menstrual Cycle in Iranian Healthy Women
107
Serum leptin concentrations in patients with short-bowel syndrome
108
Serum Leptin in Chronic Liver Disease
109
Serum leptin in Peritoneal Dialysis: Is It a Useful Biomarker Following Peritonitis?
110
Serum leptin in renal transplant patients
111
Serum leptin is associated with the perception of palatability during a standardized highcarbohydrate breakfast test
112
Serum leptin level and the risk of nontraumatic fracture
113
Serum leptin level in geriatric patients with hip fractures: Possible correlation to biochemical parameters of bone remodeling
114
Serum Leptin Level in Patients with Duodenal Ulcer
115
Serum Leptin Level Is Reduced in Non-Obese Subjects with Type 2 Diabetes
116
Serum Leptin Levels and Blood Pressure in the Overweight Elderly
117
Serum leptin levels and their proportional relationship with pro- and antiinflammatory mediators in aggressive periodontitis: preliminary report
118
Serum leptin levels are independently correlated with two measures of HDL
119
Serum Leptin Levels in Antiretroviral Therapy Naive HIV-1 Infected Patients in Zaria, Nigeria
120
Serum leptin levels in healthy ageing men: are decreased serum testosterone and increased adiposity in elderly men the consequence of leptin deficiency?
121
Serum leptin levels in Iranian patients with Parkinson s disease
122
Serum leptin levels in Iranian patients with Parkinson's disease
123
Serum leptin levels in Mexican Americans and non-Hispanic whites: Association with body mass index and cigarette smoking
124
Serum leptin levels in obese infertile men and women
125
Serum leptin levels in patients with hyperlipidemias
126
Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis
127
Serum leptin levels in post-hepatitis liver cirrhosis
128
Serum leptin levels in psoriatic patients with non-alcoholic fatty liver disease
129
Serum leptin levels in type 1 diabetic and obese children: relation to insulin levels
130
Serum leptin levels in women throughout pregnancy and the postpartum period and in women suffering spontaneous abortion
131
Serum Leptin Levels in Women with Immunological Recurrent Abortion
132
Serum Leptin Levels in Women with Immunological Recurrent Abortion
133
Serum leptin levels may be correlated with cerebral infarction
134
SERUM LEPTIN LEVELS OF MATERNAL-CORD PAIRS IN INTRAUTERINE GROWTH-RETARDED and NORMAL TERM NEONATES
135
Serum leptin profiles, food intake, and body weight in melatonin-implanted Syrian hamsters (Mesocricetus auratus) exposed to long and short photoperiods
136
Serum Leptin values in the healthy obese and non-obese subjects of Rawalpindi
137
Serum leptin, lipoprotein levels, and glucose homeostasis between national wrestlers and sedentary males
138
Serum Leptin, Plasma Glucose, and Lactate Changes following Aerobic Exhaustive Incremental Exercise in Trained 18-26 Years Old Men
139
Serum Leukocyte Count (WBC) Levels as an Indicator for Severity of Traumatic Brain Injury in Saudi Arabia Patients
140
Serum Level of Adiponectin and Its Association with Insulin Sensitivity in Overweight Diabetic and Non-Diabetic Iranian Men
141
Serum Level of Antibodies Against Novel Acinetobacter Baumannii OmpA-selected Peptides in ICU Staff: Promise for the Future of Vaccine Development
142
Serum level of anti-hepatitis B surface antigen 6–8 years after hepatitis B vaccination at birth
143
Serum Level of Anti-Hepatitis B Surface Antigen Among Students in Guilan, Iran
144
Serum Level of Anti-Mullerian Hormone in Early Follicular Phase as a Predictor of Ovarian Reserve and Pregnancy Outcome in Assisted Reproductive Technology Cycles
145
Serum Level of Antioxidant Enzymes in Opium-Addicted Patients With Coronary Artery Disease
146
Serum Level of Cortisol, hsCRP and IL-6 in Depressed Rotational Shift Workers
147
Serum Level of Desert Hedgehog Protein in Autism Spectrum Disorder: Preliminary Results
148
Serum Level of Galectin-3 in Early Detection of Acute Pancreatitis
149
Serum Level of Galectin-3 in Patients with Oral Squamous Cell Carcinoma
150
Serum Level of GDNF is Associated with Adherence to Methadone Maintenance Treatment
151
Serum Level of Heart-Type Fatty Acid-Binding Protein in Patients with Chronic Renal Failure
152
Serum Level of Heat Shock Protein 70 in Patients with Type 2 Diabetes Mellitus in Basrah, Iraq
153
Serum Level of HER-2 Extracellular Domain in Iranian Patients with Breast Cancer: A Follow-up Study
154
Serum Level of High Sensitive C-Reactive Protein in Normal and Preeclamptic Pregnancies
155
Serum Level of Homocysteine, Folate and Vitamin-B12 in Epileptic Patients Under Carbamazepine and Sodium Valproate Treatment: A Systematic Review and Meta-Analysis
156
Serum Level of Inhibin B and Kisspeptin, as well as Their Correlation with Biochemical Factors in Obese Adult Patients
157
Serum Level of Insulin-Like Growth Factor 1 in Patients with Acne Vulgaris Versus Healthy Subjects
158
Serum Level of Intercellular Adhesion Molecule-1 in Children with Malignant Lymphoma
159
Serum level of interleukin-10 with its gene polymorphism can be predictors of response to treatment in Egyptian patients with chronic hepatitis C virus
160
Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
161
Serum Level of Interleukin-17 in Patients with Erosive and Non-erosive Oral Lichen Planus
162
Serum level of interleukin‑22 in patients with psoriasis and its correlation with disease severity
163
Serum level of interleukin-4 is a possible marker of therapeutic response to interferon treatment in patients with chronic hepatitis C
164
Serum Level of Interleukin-6 in Patients with Oral Tongue Squamous cell Carcinoma
165
Serum level of Interleukin‑8 in subjects with diabetes, diabetes plus oral lichen planus, and oral lichen planus: A biochemical study
166
Serum level of Lactate dehydrogenase, Homocystein, Hemoglobin and platelet in preeclampsia
167
Serum Level of Matrix Metalloproteinase-3 in Patients with Oral Lichen Planus
168
Serum Level of Matrix Metalloproteinase-9 in Patients with Salivary Gland Tumor
169
Serum Level of Melatonin and Severity of Coronary Artery Diseases
170
SERUM LEVEL OF P53 ANTIBODY and TISSUE EXPRESSION OF P53 IN BREAST CANCER
171
Serum Level of Plasminogen Activator Inhibitor Type-1 in Addicted Patients with Coronary Artery Disease
172
Serum level of prostate-specific antigen (PSA) in women with breast cancer
173
Serum Level of Resistin in Asthmatic Children
174
Serum Level of Resistin in Patients with Hyperthyroidism and Hypothyroidism
175
Serum Level of Selenium, IL-4, IL-10 & IFN-7 in Patients with Allergic Asthma,Allergic Rhinitis and Healthy Controls
176
Serum Level of Soluble CD226 Receptor in Healthy Individuals is Highly Variable and Associated with Age
177
Serum Level of Soluble Lymphocyte-Activation Gene 3 Is Increased in Patients with Rheumatoid Arthritis
178
Serum level of thymic stromal lymphopoietin in allergic asthmatic children
179
Serum Level of Tumor Marker Carbohydrate Antigen-CA125 in Heart Failure
180
Serum Level of Vascular Cell Adhesion Molecule-1 (sVCAM-1) in Sera of Normal and Preeclamptic Pregnancies
181
Serum Level of Vascular Endothelial Growth Factor in Patients with Different Clinical SubtypeS of Oral Lichen Planus
182
Serum level of vascular endothelial growth factor is decreased by hormone replacement therapy in postmenopausal women without hypercholesterolemia
183
Serum Level of Vitamin D and Febrile Seizure? A Clinical Study
184
Serum Level of Vitamin D in Patients with Salivary Gland Tumors
185
Serum level of Vitamin D is associated with COVID‑19 mortality rate in hospitalized patients
186
Serum Level of Vitamin D3 and Renal Stone in Children
187
Serum levels assessment of vitamin A, E, C, B2and carotenoids in malnourished and non-malnourished hospitalized elderly patients
188
Serum Levels Evaluation of Heat Shock Protein70 during Gestation and Fetal Birth Weight in Asthmatic Women of Thi-QAR Province, Iraq
189
SERUM LEVELS OF 2MICROGLOBULIN AND SOME BIOCHEMICAL PARAMETERS AMONG CHRONIC HEPATITIS B PATIENTS
190
Serum levels of adhesion molecules correlate with insulin resistance
191
Serum Levels of Adipokines in Patients with Chronic HCV Infection: Relationship with Steatosis and Fibrosis
192
Serum levels of angiogenic cytokines decrease after antineoplastic radiotherapy
193
Serum Levels of Annexin A2 as a Candidate Biomarker for Hepatic Fibrosis in Patients With Chronic Hepatitis B
194
Serum Levels of Anti-Hepatitis B Surface Antibody Among Vaccinated Population Aged 1 to 18 Years in Ahvaz City Southwest of Iran
195
Serum Levels of Antioxidant Vitamins (Vitamin A, C, E)and Magnesium in Children With Allergic Rhinitis
196
Serum levels of antioxidant vitamins and mineral elements of human immunodeficiency virus positive subjects in Sokoto, Nigeria
197
SERUM LEVELS OF ANTIOXIDANT VITAMINS IN FOETAL HAEMOGLOBIN (HbF) PERSISTENT SICKLE CELL ANAEMIA CHILDREN IN SOKOTO, NIGERIA
198
Serum levels of antioxidant vitamins, copper, zinc and magnesium in children with chronic rhinosinusitis
199
Serum levels of astroglial 5100- beta and neuron-specific enolase in hepatic encephalopathy patients
200
Serum Levels of Asymmetric Dimethylarginine and Testosterone Among Egyptian Type 2 Diabetic Men with Erectile Dysfunction as Risk Markers for Coronary Artery Disease
201
Serum levels of bone alkaline phosphatase measured with a new immunoradiometric assay in patients with metabolic bone diseases
202
Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression
203
Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive–compulsive patients: A case–control study
204
Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: Relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis
205
Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deiciency during GH therapy
206
Serum Levels of Cardiac Troponin I in Patients with Status Epilepticus and Healthy Cardiovascular System
207
Serum Levels of Cardiac Troponin I in Patients with Uncomplicated Epileptic Seizure
208
Serum levels of chicken mannan-binding lectin (MBL) during virus infections; indication that chicken MBL is an acute phase reactant
209
Serum levels of chicken mannan-binding lectin (MBL) during virus infections; indication that chicken MBL is an acute phase reactant
210
Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: Results from an Italian biopsy cohort
211
Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: Results from an Italian biopsy cohort
212
Serum Levels of Copper and Zinc in Patients with Acute Coronary Syndrome
213
Serum levels of Copper, Zinc and Copper/Zinc Ratio in Patients with Ovarian Cancer
214
Serum Levels of C-reactive Protein Are Associated with Obesity, Weight Gain, and Hormone Replacement Therapy in Healthy Postmenopausal Women
215
Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women
216
Serum Levels of CXCL10 and Vitamin D in Patients with Lupus Nephritis
217
Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors
218
Serum levels of cytokines and EEG findings in children with influenza associated with mild neurological complications
219
Serum levels of different forms of soluble CD38 antigen in burned patients
220
Serum levels of eosinophil cationic protein in patients with eosinophilic myocarditis
221
Serum levels of eosinophil cationic protein, eosinophil-derived neurotoxin and myeloperoxidase in infections with filariea and schistosomes
222
Serum Levels of Epithelial-Derived Cytokines as Interleukin-25 and Thymic Stromal Lymphopoietin after a Single Dose of Mepolizumab in Patients with Severe Non-Allergic Eosinophilic Asthma: A Short Report
223
Serum Levels of Fatty Acid Binding Protein 5 Decreased in Squamous Cell Lung Carcinoma
224
Serum Levels of Ferritin, Iron, and Total Iron Binding Capacity in Cerebral Venous Sinus Thrombosis
225
Serum levels of fluconazole in patients after cytotoxic chemotherapy for hematological malignancy
226
Serum levels of folic acid and vitamin B12 in basal cell carcinoma patients: a case-control study
227
SERUM LEVELS OF FSH AND TSH IN NONFUNCTIONING PITUITARY ADENOMAS BEFORE AND AFTER SURGERY
228
Serum Levels of Glial Fibrillaryacidic Protein in Meningioma
229
Serum levels of glucagon-like peptide (GLP)-1 and GLP-2 in patients with Hashimoto’s thyroiditis
230
Serum Levels of Glutathione and Malondialdehyde in Patients with Type 2 Diabetes with Coronary Heart Disease at Khorramabad Heart Hospital, Western Iran: A Cross-Sectional Study
231
Serum Levels of Glutathione Peroxidase 3 in Overweight and Obese Subjects from Central Mexico
232
Serum Levels of Growth Differentiation Factor-15 as an Inflammatory Marker in Patients with Unstable Angina Pectoris
233
Serum levels of high-density lipoprotein phospholipids correlate inversely with severity of angiographically defined coronary artery disease
234
Serum Levels of Homocysteine, Vitamin B12, and Folic Acid in Patients with Alzheimer’s Disease.
235
Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer
236
Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer
237
Serum Levels of IL-10 and IL-17A in Occult HBV-Infected South-East Iranian Patients
238
Serum Levels of Il-12 and Il-23 in Breast Cancer Patients Infected with Toxoplasma gondii: A Case-Control Study
239
Serum levels of IL-12 and IL-23 in psoriatic patients with or without concomitant hepatitis C: a comparative study
240
Serum levels of IL-12 and the production of IFN-gamma, IL-2 and IL-4 by peripheral blood mononuclear cells (PBMC) in cancer patients treated with Viscum album extract
241
Serum levels of IL-17, IL-4, and INFγ in Serbian patients with early rheumatoid arthritis
242
Serum Levels of IL-17A Increase in Asthma But Don’t Correlate with Serum level of IgE and Asthma Severity
243
Serum Levels of Il-18 in Iranian Females with Systemic Lupus Erythematosus
244
Serum Levels of IL-22 in Patients with Oral Lichen Planus and Cutaneous Lichen Planus
245
Serum levels of immunoglobulins (IgG, IgA, IgM) in Antarctic summer expeditioners and their relationship with seasickness
246
Serum Levels of Insulin-Like Growth Factor 1, Interlukin-6, Heat-Shock Proteins-27 and Heat-Shock Proteins-60 as Inflammatory Markers of Type 2 Diabetes: A Case-Control Study
247
Serum levels of insulin-like growth factor-1 in the three months following surgery for a hip fracture in elderly: relationship with nutritional status and inflammatory reaction
248
Serum Levels of Insulin-Like Growth Factor-I, Thyroid Hormones and Skeletal Muscle Fiber Size in Castrated Lambs with and Without Androgen Treatment
249
Serum Levels of Intact Parathyroid Hormone, Calcium, and Phosphorus and Risk of Mortality in Hemodialysis Patients
250
Serum Levels of Interleukin 10 (IL-10) in Patients with Type 2 Diabetes
251
Serum Levels of Interleukin 18 and Interleukin 10 in LETTER TO THE EDITOR: Iranian Patients with Bullous Pemphigoid and Their Correlation with BP180-NC16a and BP230
252
Serum levels of interleukin-1 beta associate better with severity of simple steatosis than liver function tests in morbidly obese patients
253
Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma
254
Serum Levels of Interleukin-10 and Tumor Growth Factor-β1 in Children With Eosinophilic Gastrointestinal Disorders Compared to Control Groups
255
Serum Levels of Interleukin-10 as a Potential Indicator of Outcome in Premature Neonates with Respiratory Distress Syndrome
256
Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis Original Research Article
257
Serum levels of interleukin-12 in various clinical states with hepatitis B virus infection
258
Serum levels of interleukin-23 and 35 in patients with and without type 2 diabetes mellitus and chronic periodontitis
259
Serum Levels of Interleukin-27 and Interleukin-33 in Patients With Dermatomyositis and Polymyositis Compared to Healthy Control Subjects
260
Serum Levels of Interleukin-27 in Type 1 Diabetes Children Infected with Helicobacter Pylori and Its Association with CagA Positivity
261
Serum Levels of Interleukin-4, Interleukin-10 and Interferon-γ in Patients with Chronic Hepatitis B Infection
262
Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival
263
Serum levels of iron parameters and IL-17 in children with Helicobacter pylori infection compared to healthy group
264
Serum levels of lead and copper in a group of Egyptian children with bronchial asthma
265
Serum levels of lipid and lipoproteins in patients with beta- thalassemia in Amara S.Iraq
266
Serum Levels of Lipoprotein(a) and Homocysteine in Patients on Hemodialysis Who Take Hydroxymethylglutaryl- CoA Reductase Inhibitors, Vitamin B6, and Folic Acid
267
Serum levels of LP (a) with LDL, VLDL, and HDL in 218 hospitalized cases with AMI or UA
268
Serum levels of lycopene, beta-carotene, and retinol and their correlation with sperm DNA damage in normospermic and infertile men
269
Serum levels of macrophage colony-stimulating factor-1 in cervical human papillomavirus infection and intraepithelial neoplasia,
270
Serum levels of malondialdehyde, glutathione peroxidase and superoxide dismutase in patients with non-Hodgkin's lymphoma in Zahedan
271
Serum levels of matrix metalloproteinase 2 in patients with breast cancer
272
Serum levels of matrix metalloproteinases and tumor necrosis factor-α in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels
273
Serum levels of mdc and mmp-9 and the relationship between serum levels and disease activity in the patients with systemic lupus erythematosus
274
Serum Levels of Melatonin and Oxidative Stress Markers and Correlation between Them in Infertile Men
275
Serum Levels of Monocyte Chemoattractant Protein-1 Correlate with Poor Clinical Grades in Cerebral Aneurysms
276
Serum levels of myoglobin, creatine phosphokinase, and smooth muscle heavy-chain myosin in patients with ectopic pregnancy
277
Serum levels of neural protein S-100B in phenylketonuria
278
Serum levels of osteoprotegerin and receptor activator of nuclear factor kB ligand (RANKL) in children with various stages of chronic renal disease
279
Serum levels of osteoprotegerin increase with age in a healthy adult population
280
Serum levels of PCDDs, PCDFs and PCBs in non-occupationally exposed population groups living near two incineration plants in Tuscany, Italy Original Research Article
281
Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples
282
Serum levels of polychlorinated dibenzo-p-dioxins and dibenzofurans in pulp and paper mill workers
283
Serum Levels of Prolactin and Complement Components (C3 and C4) in Women Infected with Trichomonas vaginalis
284
Serum levels of prophylactic cefazolin during cardiopulmonary bypass surgery
285
Serum levels of selected adhesion molecules in patients with coronary artery disease
286
Serum Levels of Selenium and Zinc in Patients with Breast Cancer: A Case-Control Study
287
Serum levels of selenium in patients with brain metastases from non-small cell lung cancer before and after radiotherapy
288
Serum levels of serotonin as a biomarker of newly diagnosed fibromyalgia in women: Its relation to the platelet indices
289
Serum Levels of Sialic Acid and Neuraminidase Activity in Cardiovascular, Diabetic and Diabetic Retinopathy Patients
290
Serum levels of smooth muscle heavy-chain myosin in patients with ectopic pregnancy
291
Serum levels of soluble adhesion molecules ICAM-1, VCAM-1 and E-selectin in patients with Wegenerʹs granulomatosis
292
Serum Levels of Soluble CD26, A Novel Prognostic Marker for Hepatitis E Infection
293
Serum Levels of Soluble Fas and Fas Ligand in Iranian Women with Pre-eclampsia
294
Serum levels of soluble Fas antigen in chronic hepatitis C patients
295
Serum Levels of Soluble Form of Fas Molecule in Patients with Congestive Heart Failure
296
Serum Levels of Soluble Fractalkine in Active Systemic Lupus Erythematosus and its Relation to Disease Activity and Renal Impairment
297
Serum levels of sTNF-R1, sTNF-R2 and CXCL9 correlate with disease activity in adult type paracoccidioidomycosis
298
Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia
299
Serum Levels of Tetranectin, Intercellular Adhesion Molecule-1 and lnterleukin-10 in B-Chronic Lymphocytic Leukemia
300
Serum Levels of Th2-Type Immunoglobulins are Increased in Weanling Mice Subjected to Acute Wasting Protein-Energy Malnutrition
301
Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease
302
Serum levels of the pyridinoline crosslinked carboxyterminal telopeptide of type I collagen (ICTP) and osteocalcin in rachitic children in Nigeria
303
Serum levels of the TGF-beta receptor are increased in atherosclerosis
304
Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease: A longitudinal analysis of the PREVENT study Original Research Article
305
SERUM LEVELS OF THROMBOMODULIN, INTERCELLULAR ADHESION MOLECULE-1, VASCULAR CELL ADHESION MOLECULE-1, AND E-SELECTIN IN THE ACUTE PHASE OF PLASMODIUM VIVAX MALARIA
306
Serum Levels of Thyroid Hormones as Biological Markers in a Swedish Forensic Psychiatric Population
307
Serum Levels of TNF-a, IL-6, and Selenium in Patients with Acute and Chronic Coronary Artery Disease
308
Serum Levels of TNF-α, TNF-αRI, TNF-αRII and IL-12 in Treated Rheumatoid Arthritis Patients
309
Serum Levels of Total Immunoglobulin E in Patients with Psoriasis: Relationship with Clinical Type of Disease
310
Serum Levels of Triamcinolone Acetonide After Intravitreal Injection
311
Serum levels of tumor necrosis factor-α, interleukin-15 and interleukin-10 in patients with pre-eclampsia in comparison with normotensive pregnant women
312
Serum levels of vancomycin should be monitored in burn patients
313
Serum levels of VEGF and basic FGF in the subacute phase of myocardial infarction
314
Serum levels of visfatin, sirtuin‑1, and interleukin‑6 in stable and acute exacerbation of chronic obstructive pulmonary disease
315
SERUM LEVELS OF VITAMIN B12, FOLATE AND HOMOCYSTEINE IN WOMEN WITH HISTORY OF RECURRENT EARLY PREGNANCY LOSS
316
Serum levels of vitamin B12, folic acid, and homocysteine in patients with vitiligo
317
Serum Levels of Vitamin D in Diabetic Patients With and Without Retinopathy
318
serum levels of vitamin d, magnesium, calcium, iron, and tibc in hiv-infected patients
319
Serum Levels of Vitamin D, Retinol and Zinc in Relation to overweight among Toddlers: Findings from a National Study in Iran
320
Serum levels of vitamins A and D, and zinc in children with acute diarrhea: A cross-sectional study
321
Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease
322
Serum levels of zinc, copper, selenium and glutathione peroxidase in the different groups of colorectal cancer patients
323
Serum Levels of Zinc, Copper, Vitamin B12, Folate and Immunoglobulins in Individuals with Giardiasis
324
SERUM LEVELS OF ZN, CU, CR AND NI IN IRANIAN SUBJECTS WITH ATHEROSCLEROSIS
325
Serum levonorgestrel concentration and cervical mucus viscosity after six months of monoplant® implantation
326
Serum LH peak and ovulation following synchronized estrus in goats
327
Serum LH, FSH, estradiol-17β and progesterone profiles of native and crossbred goats in a tropical semiarid zone of Venezuela during the estrous cycle
328
SERUM LIPID AND GLUCOSE CONCENTRATION IN RELATION TO SOME PHYSIOLOGICAL VARIBLES IN COLLEGE STUDENTS FROM NNEWI, NIGERIA
329
Serum lipid and lipoprotein levels, dyslipidemia prevalence,and the factors that influence these parameters in a Turkish population living in the province of Tokat
330
Serum lipid changes following large-volume suction lipectomy
331
Serum lipid concentration in relation to anthropometric indices of central and peripheral fat distribution in 20,021 British men and women: Results from the EPIC-Norfolk population-based cohort study
332
Serum Lipid Concentrations in Iranian Veterans with Combat-Related Chronic Posttraumatic Stress Disorder
333
Serum lipid concentrations in patients with major depressive disorder
334
Serum lipid levels during carbamazepine therapy in epileptic children
335
Serum lipid levels in a major league baseball team
336
Serum lipid peroxide and other enzyme levels of patients suffering from thermal injury
337
Serum Lipid Profile Alterations in Acute Leukemia Before and After Chemotherapy
338
Serum Lipid Profile and Steroid Hormone Levels in Patients With Colorectal Cancer
339
Serum Lipid Profile Changes After Bariatric Surgery
340
Serum lipid profile in patients with oral cancer and oral precancerous conditions
341
Serum lipid profile of Parkinson's disease patients: A study from the Northwest of Iran
342
Serum Lipid Profile status of Type 2 Diabetic Patients in the cross section population in Dhaka City of Bangladesh
343
Serum Lipid Profile, Liver Function Indices and Electrolyte Levels in Diabetics and Subjects with Hepatic Impairment in the University of Port Harcourt Teaching Hospital
344
Serum Lipid Profiles and the Presence of Yellow Plaque in Coronary Lesions In Vivo
345
Serum Lipid Profiles in Hypertensive Diabetes Mellitus Type 2 Patients
346
Serum lipid profiles in major depression with clinical subtypes, suicide attempts and episodes
347
Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran
348
Serum lipid profiles with and without CAD: Jordan Hyperlipidaemia and Related Targets Study (JoHARTS-1)
349
Serum lipid values in adolescents are related to family history, infant feeding, and physical growth Original Research Article
350
Serum Lipids and Arterial Plaque Load are Altered Independently with High-Dose Progesterone in Hypercholesterolemic Male Rabbits
351
Serum Lipids and Cardiovascular Disease Mortality in Iranian Population: Joint Modeling of Longitudinal and Survival Data in Tehran Lipid and Glucose Study (TLGS) Cohort
352
Serum Lipids and Glucose Abnormalities in HIV/AIDS Patients on Antiretroviral Therapies
353
Serum Lipids and Lipoproteins Among Students of the University of Sarajevo
354
Serum Lipids and Lipoproteins in Patients with Psoriasis
355
Serum Lipids During 20 Years in the Tehran Lipid and Glucose Study: Prevalence, Trends and Impact on Non-Communicable Diseases
356
Serum lipids in relation to sciatica among Finns
357
Serum lipids responses to a respite from occupational and domestic demands in subjects with varying levels of stress
358
Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery Original Research Article
359
Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites
360
Serum lipoprotein (a) and atherosclerotic changes in hemodialysis patients
361
Serum lipoprotein (a) as an atherosclerosis risk factor in men with androgenic alopecia
362
Serum Lipoprotein Profiles and Response to Pegylated Interferon Plus Ribavirin Combination Therapy in Patients With Chronic HCV Genotype 1b Infection
363
Serum lipoprotein(a) [Lp(a)] in alcoholic men: Effect of withdrawal
364
Serum lipoprotein(A) in type II diabetes patients with coronary heart disease
365
Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals
366
Serum Lipoprotein-a Levels and Glyco-Metabolic Control in Insulin and Non-Insulin Dependent Diabetes Mellitus
367
Serum lipoxin A4 as a biomarker for systemic lupus erythematosus
368
Serum liver enzymes profile of Wistar rats following chronic consumption of fresh or oxidized palm oil diets
369
Serum Liver Proteins and 17𝛽-estradiol in Postmenopausal Women with Breast Cancer
370
Serum long-chain polyenoic fatty acids in postmenopausal women
371
Serum Lp-PLA2: as a novel viewpoint in periodontal treatment of hyperlipidaemics
372
Serum Lycopene, Other Serum Carotenoids, and Risk of Prostate Cancer in US Blacks and Whites
373
Serum Lysophosphatidic Acid as a Potential Biomarker of Prostate Cancer
374
Serum Lysophosphatidic Acid Level in Chronic Myeloid Leukemia
375
Serum lysozyme concentrations in broilers treated with Sel-Plex® and sodium selenite and infected with Еimeria tenella
376
Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Can Predict Mild or Significant Liver Fibrosis in Non-alcoholic Fatty Liver Disease
377
Serum Macromineral Levels in Estrual, Fertile, Subfertile and Pregnant Mares Kept Under Two Different Managemental Conditions
378
Serum Macrominerals, Glucose and Triglycerides in Arabian Mares during Different Phases of Reproduction Cycle
379
Serum Macrophage Colony-Stimulating Factor (M-CSF) Level Is Elevated in Patients With Old Cerebral Infarction Related to Vascular Damage
380
Serum magnesium and lipids: More clarity is needed
381
Serum Magnesium and Phosphate Levels in Metabolic Syndrome
382
Serum magnesium and the development of diabetes
383
Serum magnesium concentration in gastrointestinal tract (GIT) diseases
384
Serum Magnesium Level and Cardiovascular Disease in Dialysis Patients
385
Serum Magnesium Level Impact on the Outcome of Patients Admitted to the Intensive Care Unit
386
Serum Magnesium Level of Patients Admitted to the Pediatric Intensive Care Unit: A Prospective Analytical Study
387
Serum Magnesium Levels in Children with Type 1 Diabetes Mellitus in Northwest Iran
388
Serum Magnesium Levels in Neonatal Jaundice: Is There any Correlation Between Hypermagnesemia and Moderate to Severe Hyperbilirubinemia in Term Newborns?
389
Serum Malondialdehyde and Urinary Neopterin Levels in Glass Sandblasters Exposed to Crystalline Silica Aerosols
390
Serum Malondialdehyde in HIV Seropositive Children
391
Serum Malondialdehyde Levels Decreased Along with the Alleviating Effects of Marrubium Parviflorum on Morphine Withdrawal Syndrome in Rats
392
Serum malondialdehyde: possible use for the clinical management of chronic hepatitis C patients
393
Serum Mannan-Binding Lectin in Egyptian Patients With Chronic Hepatitis C: Its Relation to Disease Progression and Response to Treatment
394
Serum mannan-binding lectin in patients with pulmonary tuberculosis: Its lack of a relationship to the disease and response to treatment
395
Serum Mannose-binding Lectin in Patients on Peritoneal Dialysis Compared With Healthy Individuals
396
Serum Markers as a Predictor of Hepatic Fibrosis Compared to Fibroscan in chronic hepatitis B Infected Egyptian patients: A Cross-sectional Study
397
Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C: A comparative analysis
398
Serum Markers of Collagen Turnover Predict Future Shocks in Implantable Cardioverter-Defibrillator Recipients With Dilated Cardiomyopathy on Optimal Treatment
399
Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease
400
Serum markers of monocyte/macrophage activation in patients with Alzheimerʹs disease and other types of dementia
401
Serum markers support disease-specific glial pathology in major depression
402
Serum matrix metalloproteinase 7 (MMP-7) and liver function in biliary atresia
403
Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients
404
Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease
405
Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia
406
Serum Matrix Metalloproteinase-3 in Adult and Juvenile SLE Patients in Relation to Arthritis and Nephritis
407
Serum Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9/ Neutrophil Gelatinase-associated Lipocalin Complex Levels in Patients with Early-stage Diabetic Nephropathy
408
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimerʹs disease
409
Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome
410
Serum metabolic profiling of abnormal savda by liquid chromatography/mass spectrometry
411
Serum Metabolic Profiling of Advanced Cirrhosis Based on HCV
412
Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry
413
Serum metabolites of proanthocyanidin-administered rats decrease lipid synthesis in HepG2 cells
414
Serum metabolomic profiles from patients with acute kidney injury: A pilot study
415
Serum Metabonomics Analysis of Liver Failure Treated by Nonbioartificial Liver Support Systems
416
Serum Methanol in the Absence of Methanol Ingestion
417
Serum Methanol in the Absence of Methanol Ingestion
418
Serum methylarginines and incident depression in a cohort of older adults
419
Serum Micronutrient and Micromineral Concentrations and Ratios in Healthy Omani Subjects
420
Serum micronutrient levels and disease severity score in patients with sickle cell anaemia
421
Serum midkine predicts cardiac events in patients with heart failure
422
Serum Mineral Profile in Various Reproductive Phases of Mares
423
Serum miR-210 and miR-30a expressions tend to revert to fetal levels in Chinese adult patients with chronic heart failure
424
Serum Mn-Superoxide Dismutase in Acute Myocardial Infarction
425
Serum modulates the intracellular calcium response of primary cultured bone cells to shear flow
426
Serum molybdenum concentration in healthy Japanese adults determined by inductively coupled plasma-mass spectrometry
427
Serum monoclonal and polyclonal free light chains in newly diagnosed Egyptian patients with diffuse large B‑cell lymphoma: their impact on event‑free and overall survival
428
Serum Monocyte Chemoattractant Protein-1 and Monocyte Adhesion Molecules in Type 1 Diabetic Patients with Nephropathy
429
Serum MUC5AC mucin as a potential marker for cholangiocarcinoma
430
Serum Myeloperoxidase as a Biomarker of Asthma Severity Among Adults: A Case Control Study
431
Serum Myeloperoxidase Level Is Associated with Heart-Type Fatty Acid-Binding Protein but Not Troponin T in Patients with Chronic Heart Failure
432
Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals: The EPIC-Norfolk Prospective Population Study Original Research Article
433
Serum Myoglobin in Patients with Thyroid Dysfunction
434
Serum myoglobin/carbonic anhydrase III ratio as a marker of reperfusion after myocardial infarction
435
Serum N-acetyl-β- -gulucosaminidase activity increases in association with insulin resistance in patients with coronary artery disease
436
Serum neopterin and complex stenosis morphology in patients with unstable angina
437
Serum neopterin for early assessment of severity of severe acute respiratory syndrome
438
Serum neopterin in acute coronary syndromes
439
Serum neopterin in acute coronary syndromes
440
Serum Neopterin Level in Systemic Lupus Erythematosus: Could it be used as an Immunemarker of Disease Activity and its Comparison with other Disease Activity Parameters
441
Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non–Q-wave acute myocardial infarction
442
Serum neopterin, tumor necrosis factor-α and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus
443
Serum neopterin, tumor necrosis factor-α and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus
444
Serum Neoptrin Level as a Marker for Activity in Chronic Hepatitis B Virus Infection
445
Serum neuron-specific enolase in children with febrile seizures: time profile and prognostic implications
446
Serum Neuron-Specific Enolase in Lead-Exposed Individuals
447
Serum Neuron-Specific Enolase, Biogenic Amino-Acids and Neurobehavioral Function in Lead-Exposed Workers from Lead-Acid Battery Manufacturing Process
448
Serum neurotrophic factors in adolescent depression: Gender difference and correlation with clinical severity
449
Serum neurotrophin concentrations in autism and mental retardation: a pilot study
450
Serum neurotrophins—A study on the time course and influencing factors in a large old age sample
451
Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir
452
Serum neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis
453
Serum neutrophil gelatinase-associated lipocalin levels are correlated with the complexity and the severity of atherosclerosis in acute coronary syndrome
454
Serum Neutrophil Gelatinase-Associated Lipocalin versus Serum Creatinine for the Prediction of Acute Kidney Injury after Liver Transplantation
455
Serum nifedipine concentrations and response of patients with pulmonary hypertension
456
Serum nitrates and creatinine in workers exposed to atmospheric nitrogen oxides and ammonia
457
Serum nitrates and vasoactive intestinal peptide in patients with gastroesophageal reflux disease
458
Serum nitric oxide and peroxynitrite levels in adult sero-positive rheumatoid arthritis treated with disease modifying antirheumatic drugs: a preliminary report
459
Serum nitric oxide level in patients with coronary artery ectasia
460
Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia
461
Serum nitric oxide metabolites in leprosy patients as a parameter of prognostic value
462
Serum nitric oxide metabolites in subjects with metabolic syndrome
463
Serum nitric oxide, asymmetric dimethylarginine, and plasma homocysteine levels in active Behçet’s disease
464
Serum nitrite and nitrate levels in epileptic children using valproic acid or carbamazepine
465
Serum Non-Esterified Fatty Acids and Beta-Hydroxybutyrate in Dairy Cows with Retained Placenta
466
Serum nonesterified fatty acids, ghrelin, and homocysteine levels in women with polycystic ovary syndrome
467
Serum non-esterified very long-chain PUFA are associated with markers of endothelial dysfunction
468
Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients
469
Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease
470
Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C
471
Serum oestradiol and progesterone profiles and their relationship with superovulatory responses in Tellicherry goats treated with eCG and FSH
472
Serum oestradiol and progesterone profiles and their relationship with superovulatory responses in Tellicherry goats treated with eCG and FSH
473
Serum Oestradiol Pattern during Coasting is Different in Antagonist Cycles Compared with Long Agonist Cycles in In Vitro Fertilisation
474
Serum Omentin-1 Levels in Obese Adolescents with Vitamin D Deficiency: A Prospective Cross-sectional Study
475
Serum omentin‑1, vaspin, and apelin levels and central obesity in patients with nonalcoholic fatty liver disease
476
Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Pagetʹs disease of bone
477
Serum organochlorine levels and history of lactation in Egypt
478
Serum Ostʹeocalcin Increases During Fracture Healing in Elderly Women With Hip Fracture
479
Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome
480
Serum osteoprotegerin (OPG) measurement in Behcet’s disease
481
Serum Osteoprotegerin as a Biomarker for Vascular Disease
482
Serum Osteoprotegerin in Relation to Metabolic Status, Severity, and Estimated Risk of Subsequent Coronary Heart Disease
483
Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation
484
Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis
485
Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans
486
Serum Ovarian Steriod Hormones and Some Minerals Concentration in Pregnant Nili-Ravi Buffaloes with or without Pre-Partum Vaginal Prolapse
487
Serum oxidizability, total antioxidant status and albumin serum levels in patients with aneurysmal or arterial occlusive disease
488
Serum ox-LDL level and severity of stenosis in coronary arteries.
489
Serum ox-LDL level is reduced with the extent of stenosis in coronary arteries.
490
Serum p53 antibodies in correlation to other biological parameters of breast cancer
491
Serum p53 autoantibodies: incidence in ovarian carcinoma
492
Serum palmitic acid–oleic acid ratio and the risk of coronary artery disease: a case-control study
493
Serum pancreatic lipase [EC 3.1.1.3] activity, serum lipid profile and peripheral blood dendritic cell populations in normolipidemic males with psoriasis
494
Serum Parameters and Echocardiographic Predictors of Death or Need for Transplant in Newborns, Children, and Young Adults With Heart Failure
495
Serum parameters, diet and body mass index in acne vulgaris: a mini review
496
Serum paraoksonaz-1 aktivitesinin izole koroner arter ektazisi ile ilişkisi: Gözlemsel bir çalışma
497
Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus Original Research Article
498
Serum Paraoxonase 1 Activity and Oxidative Stress in Pediatric Patients with Pulmonary Tuberculosis
499
Serum Paraoxonase 1 Activity in Patients with Organophosphate Poisoning: A Potential Indicator of Prognosis
500
Serum paraoxonase activity and lipid hydroperoxide levels in adult football players after three days football tournament
501
Serum paraoxonase and arylesterase activities in iron deficiency anemia during pregnancy
502
Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation
503
Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection
504
Serum paraoxonase-1 activity in Helicobacter pylori infected subjects
505
Serum paraoxonase-1 activity in neonatal calves: Age related variations and comparison between healthy and sick animals
506
Serum paraoxonase-1 in chronic alcoholics: Relationship with liver disease
507
Serum Parathormone Levels as a Sign for Vitamin D Deficiency During Anti-Tuberculosis Therapy, a Pilot Study
508
Serum PCB and DDE Levels of Frequent Great Lakes Sport Fish Consumers—A First Look
509
Serum PCB profiles in Native Americans from Wisconsin based on region, diet, age, and gender: Implications for epidemiology studies
510
Serum PCBs and organochlorine pesticides in Slovakia: Age, gender, and residence as determinants of organochlorine concentrations
511
Serum PCBs, p,p′-DDE and HCB predict thyroid hormone levels in men
512
Serum PCDD/F concentration distribution in residents living in the vicinity of an incinerator and its association with predicted ambient dioxin exposure
513
Serum Pentraxin 3 and hs-CRP Levels in Children with Severe Pulmonary Hypertension
514
Serum Pentraxin-3 Level in Patients Who Underwent Coronary Angiography and Relationship with Coronary Atherosclerosis
515
Serum Pentraxin-3 Levels Are Associated with the Severity of Metabolic Syndrome
516
Serum pepsinogen level and abomasal ulcerations in experimental abomasal displacement in sheep
517
Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer—A prospective cohort study
518
Serum peptide profiles in patients with carcinoid tumors
519
Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay
520
Serum Peptidyl-prolyl Cis-trans Isomerase NIMA-interacted 1 (Pin1) as a Non-invasive Marker for Liver Fibrosis due to Chronic Hepatitis C Virus.
521
Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps
522
Serum pharmacokinetics of oxytetracycline in sheep and calves and tissue residues in sheep following a single intramuscular injection of a long-acting preparation
523
Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8
524
Serum Phosphate Concentrations: A Novel Pre-Clinical Biomarker for Cardiovascular Calcification
525
Serum Phospholipase A2-IIA, hs-CRP, and Lipids in Women With Subclinical Hypothyroidism
526
Serum phospholipid transfer protein activity and genetic variation of the PLTP gene
527
Serum Plant Sterols and Atherosclerosis: Is There a Place for Statin-Ezetimibe Combination?
528
Serum platelet-activating factor acetylhydrolase and paraoxonase-1 activity in horses infected with Leptospira spp
529
Serum platelet-derived growth factor-BB in adult patients with aggressive non-Hodgkin’s lymphoma
530
Serum polyamines in pre- and post-operative patients with breast cancer corrected by menopausal status
531
Serum polychlorinated biphenyl and organochlorine insecticide concentrations in a Faroese birth cohort
532
Serum potassium and stroke risk among treated hypertensive adults
533
Serum potassium is not associated with blood pressure tracking in the Framingham heart study
534
Serum potassium level and risk of postoperative atrial fibrillation in patients undergoing cardiac surgery
535
Serum Procalcitonin and Lactoferrin in Detection of Acute Appendicitis; a Diagnostic Accuracy Study
536
SERUM PROCALCITONIN AS A GOOD MARKER FOR DIAGNOSIS AND PROGNOSIS OF VENTILATOR ASSOCIATED PNEUMONIA
537
Serum Procalcitonin level and other biological markers in children with bacterial or non-bacterial meningitis
538
Serum Procalcitonin Level as a Predictor of Bacterial Infection in Patients with COPD Exacerbation
539
Serum Procalcitonin Level for Prediction of High-grade Vesicoureteral Reflux in Urinary Tract Infection
540
Serum Procalcitonine Levels as an Early Diagnostic Indicator of Sepsis
541
Serum procollagen type 1 N propeptide: A novel diagnostic test for diabetic foot osteomyelitis – A case–control study
542
Serum Profile of T Helper 1 and T Helper 2 Cytokines in Hepatitis C Virus Infected Patients
543
Serum profiles of calcium, phosphorus, magnesium, vitamin D and parathyroid hormone in Caspian horses during different seasons
544
Serum profiles of granulocyte-macrophage colony-stimulating factor and C-C chemokines in hypertensive patients with or without significant hyperlipidemia
545
Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration
546
Serum profiles of PCDDs and PCDFs, in individuals near the Escambia Wood Treating Company Superfund site in Pensacola, FL Original Research Article
547
Serum Progesterone and Estradiol-17β Profiles in Nili Ravi Buffaloes (Bubalus bubalis) with and without Dystocia
548
SERUM PROGESTERONE AND ESTRADIOL-17β PROFILES IN NILI RAVI BUFFALOES (BUBALUS BUBALIS) WITH AND WITHOUT RETENTION OF FETAL MEMBRANES
549
Serum progesterone as an indicator of cyclic activity in post-partum goat does
550
Serum Progesterone Concentration and Ongoing Pregnancy Rate in Frozen-Thawed Embryo Transfers with Intramuscular Plus Vaginal Progesterone Administration for Endometrial Preparation
551
Serum Progesterone Levels with The Use of Four Different Types of Vaginal Progesterone in Frozen-Thawed Embryo Transfer Cycles and Related Pregnancy Outcomes
552
Serum progesterone profiles of zebu cattle (Bos indicus) in relationship to conception and repeat breeding after artificial insemination
553
Serum progesterone testing to predict ectopic pregnancy in symptomatic first-trimester patients
554
Serum progesterone, oestradiol, luteinizing hormone and prolactin profiles in the female black bear (Ursus americanus)
555
SERUM PROHEPCIDIN AND INTERLEUKIN-6 IN CHLORAMPHENICOL CHALLENGED LIVER OF WISTAR RAT MODELS
556
Serum prohepcidin is associated with soluble transferrin receptor-1 but not ferritin in healthy post-menopausal women
557
Serum prolactin and migraine.
558
Serum Prolactin Level after Febrile Seizure versus Epileptic Seizure in 6-Month-Old to 5-Year-Old Children.
559
Serum prolactin level in multiple sclerosis patients
560
Serum prolactin level in psoriasis
561
Serum prolactin level in psoriasis: Is it really higher than in healthy individuals?
562
Serum Prolactin Level in Yemeni Females with Breast Cancer
563
Serum prolactin levels and behavior in infants
564
Serum prolactin levels for differentiation of nonepileptic versus true seizures: limited utility
565
Serum prolactin levels in dermatological diseases: A case–control study
566
Serum prolactin, growth hormone, total corticoids, thyroid hormones and thyrotropine during serial therapeutic sleep deprivation
567
Serum Prolactin: A Clue to Breast Malignancy
568
Serum prolidase activity and oxidative status in Helicobacter pylori infection
569
Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus
570
Serum prolidase activity in patients with degenerative and rheumatic heart valve diseases
571
Serum prolidase activity in patients with hypertension and its relation with left ventricular hypertrophy
572
Serum prolidase I activity and some bone metabolic markers in patients with breast cancer: in relation to menopausal status
573
Serum Pro-oxidant-Antioxidant Balance Assay in Nurses who Working Day and Rotating Night Shift
574
Serum Pro-Oxidant-Antioxidant Balance, Advanced Oxidized Protein Products (AOPP) and Protein Carbonyl in Patients With Stroke
575
Serum prostate specific antigen, sex hormone binding globulin and free androgen index as markers of pubertal development in boys
576
Serum Prostate-Specific Antigen Levels in Middle Eastern Men with Subclinical Prostatitis
577
Serum protein acrolein adducts: utility in detecting oxidant stress in hemodialysis patients and reversal using a vitamin E-bonded hemodialyzer
578
Serum protein adsorption and platelet adhesion on pluronic™-adsorbed polysulfone membranes
579
Serum protein alterations in goats naturally infected with Babesia ovis
580
Serum protein and prolactin as diagnostic markers
581
Serum protein carbonyl and total antioxidant capacity levels in pemphigus vulgaris and bullous pemphigoid
582
Serum protein electrophoresis pattern in patients living with HIV: frequency of possible abnormalities in Iranian patients
583
Serum Protein Electrophoresis: Any role in monitoring for Antiretroviral Therapy?
584
Serum protein electrophoresis: false negative rate based on immunofixation
585
Serum protein electrophoretic pattern in one-humped camels (Camelus dromedarius) in Tripoli, Libya
586
Serum Protein Expression Predicts Recurrence in Patients With Early-Stage Lung Cancer After Resection
587
Serum Protein Fraction in Mature Horses and Relationship With Metabolic and Hematological Parameters
588
Serum protein layers on parylene-C and silicon oxide: Effect on cell adhesion
589
Serum protein level in conjunction with serum albumin/globulin ratio as an indicator of severity of changes in capillary permeability
590
Serum Protein of 135-kDa Molecular Weight-A Molecular Signal for Cardiac Hypertrophy
591
Serum Protein of Female Holstein Calves Fed Milk through Step-Down and Conventional Methods
592
Serum Protein Profile Of Iraqi Hydatidosis Patients with Different Sites of Infection
593
Serum Protein Profile of Lori‐Bakhtiari Ewes in Relation to Age, Body Weight, Birth Type and Birth Season
594
Serum protein profile of rheumatoid arthritis treated with anti-TNF therapy (infliximab)
595
Serum Protein Profiles of Juvenile Ring-Necked Pheasants Vaccinated or Not Against Newcastle Disease
596
Serum protein profiling using surfactant-aided matrix-assisted laser desorption/ionization mass spectrometry Original Research Article
597
Serum Proteinogram of Chinese Goose (Anser cygnoides) Vaccinated or Not Against Newcastle Disease
598
Serum proteins and nutritional status of free-living Thai elderly
599
Serum Proteins by Capillary Zone Electrophoresis: Approaches to the Definition of Reference Values
600
Serum proteins with NAD+ glycohydrolase activity and anti-CD38 reactivity – elevated levels in serum of tumour patients
601
Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: Association to tumor derived alpha-N-acetylgalactosaminidase activity
602
Serum Proteomic Profiling of Obsessive-Compulsive Disorder, Washing Subtype: A Preliminary Study
603
Serum Proteomic Profiling of Obsessive-Compulsive Disorder, Washing Subtype: A Preliminary Study
604
Serum proteomics in patients with diagnosis of abdominal aortic aneurysm
605
Serum PSA testing frequency: A potent indicator of biochemical and clinical failure
606
Serum reference levels of selenium, zinc and copper in healthy pregnant women at a prenatal screening program in southeastern mediterranean region of Turkey
607
SERUM REGENERATING ISLET-DERIVED 1 ALPHA (REG1α) PROTEIN LEVELS AS BIOMARKER FOR TYPE 1 2 DIABETICS
608
Serum relaxin, symphyseal pain, and back pain during pregnancy, , ,
609
Serum release boosts sweetness intensity in gels
610
Serum release: The hidden quality in fracturing composites
611
Serum resistin a biomarker of type II diabetes development
612
Serum resistin a biomarker of type II diabetes development
613
Serum Resistin as a Biomarker for Hepatic State in HCV Infected Patients and its Relation to Insulin Resistance
614
Serum Resistin as a Predictor of Outcome in Traumatic Head-Injured Patients in Intensive Care Unit of Suez Canal University Hospital
615
Serum Resistin levels in bladder cancer
616
Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus
617
Serum response factor: toggling between disparate programs of gene expression
618
Serum response of hepatocyte growth factor, insulin-like growth factor-I, interleukin-6, and acute phase proteins in patients with colorectal liver metastases treated with partial hepatectomy or cryosurgery
619
Serum retinol and (alpha)-tocopherol levels in healthy Asian subjects and patients
620
Serum retinol and risk of hepatocellular carcinoma in patients with child-Pugh class A cirrhosis
621
Serum ribonuclease activity in the diagnosis of prostate cancer in men with serum prostate-specific antigen levels between 2.5 and 20 ng/mL
622
Serum S100 Protein as a Predictor of Long Term Outcome in Mild and Moderate Traumatic Brain Injury
623
Serum S100 protein: A potential marker for cerebral events during cardiopulmonary bypass
624
Serum S-100 β Protein During Coronary Artery Bypass Graft Surgery With or Without Cardiopulmonary Bypass
625
Serum S100B and antioxidant enzymes in bipolar patients
626
Serum S100B and hypothermic circulatory arrest in adults
627
Serum S100B Protein Is Increased in Fasting Rats
628
Serum S100β release after coronary artery bypass grafting: roller versus centrifugal pump
629
Serum sample levels of selenium and copper in healthy volunteers living in Rio de Janeiro city
630
Serum sCD23 Level in Patients with AIDS-Related Non-Hodgkinʹs Lymphoma Is Associated with Absence of Epstein–Barr Virus in Tumor Tissue
631
Serum secretory IgA and secretory component in patients with non-cirrhotic alcoholic liver diseases
632
Serum selenium and glutathione peroxidase activity in critically ill patients with Systemic Inflammatory Response and Multiple Organ Dysfunction Syndromes
633
Serum selenium and selenoprotein P in patients with silicosis
634
Serum selenium and selenoprotein P status in adult Danes – 8-year followup
635
Serum selenium concentration in a representative sample of the Canarian population
636
Serum selenium in adult Taiwanese
637
Serum Selenium Level in Patients with Gastric Non-Cardia Cancer and Functional Dyspepsia
638
Serum selenium levels as indicators of body status in cancer patients and their relationship with other nutritional and biochemical markers
639
Serum selenium levels during normal pregnancy in healthy Spanish women
640
Serum selenium levels in alopecia areata
641
Serum selenium levels of the very low birth weight premature newborn infants with bronchopulmonary dysplasia
642
Serum Selenium Status Among Populations in Hulu Langat District, Selangor, Malaysia
643
Serum Selenium, Lipoproteins and Testosterone Responses to a Single Session of Circuit Resistance Exercise in Male College Students
644
Serum Selenium, Zinc, and Copper in Early Diagnosed Patients with Pemphigus Vulgaris
645
Serum selenoprotein-P levels in patients with inflammatory bowel disease
646
Serum separation and structure of depletion- and bridging-flocculated emulsions: a comparison
647
Serum separator tube method for matrix-assisted laser desorption/ionization time-of-flight analysis
648
Serum sex hormone levels and renin-sodium profile in men with hypertension
649
Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia
650
SERUM sFas/sFasL RATIO IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IS A FUNCTION OF AGE
651
Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women
652
Serum sialic acid and sialoglycoproteins in asymptomatic carotid artery atherosclerosis
653
Serum sialic acid concentration is not associated with the extent or severity of coronary artery disease in patients with stable angina pectoris, , ,
654
Serum sirtuin 1 protein as a potential biomarker for type 2 diabetes: Increased expression of sirtuin 1 and the correlation with microRNAs
655
Serum Sodium Alterations in Children with Primary Monosymptomatic Nocturnal Enuresis Using Desmopressin
656
Serum Sodium Changes in Fluoxetine Users at Different Age Groups
657
Serum soluble Fas in children with acute rheumatic carditis
658
Serum soluble Fas levels in patients with autoimmune rheumatic diseases
659
Serum Soluble Intercellular Adhesion Molecule-1 in Normal Pregnant Women and Those with Pre-eclampsia
660
Serum Soluble Interleukin-2 Receptor Alpha in Systemic Lupus Erythematosus
661
Serum soluble interleukin–2 receptor concentrations as an independent prognostic marker in head and neck cancer
662
Serum soluble interleukin-2-receptor concentrations
663
Serum Soluble ST2 as a Biochemical Marker of Acute Heart Failure: Future Areas of Research
664
Serum Soluble ST2: A Potential Novel Mediator in Left Ventricular and Infarct Remodeling After Acute Myocardial Infarction
665
Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors
666
Serum sphingolipid level in psoriatic patients with obesity
667
Serum squalene in postmenopausal women without and with coronary artery disease
668
Serum stability of phosphopeptides
669
Serum sterols in patients with primary biliary cirrhosis and acute liver failure before and after liver transplantation
670
Serum Strontium and Antimony Levels in Patients with Esophageal Cancer and Healthy People
671
Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients
672
Serum superoxide dismutase 3 (extracellular superoxide dismutase) activity is a sensitive indicator of Cu status in rats
673
Serum surfactant protein D is correlated to development of dementia and augmented mortality
674
Serum Survivin and TP53 Gene Expression in Children with Acute Lymphoblastic Leukemia
675
Serum Survivin in Patients with Rheumatoid Arthritis
676
Serum Tenascin-C Might Be a Novel Predictor of Left Ventricular Remodeling and Prognosis After Acute Myocardial Infarction Original Research Article
677
Serum test for assessment of patients with Bence Jones myeloma
678
Serum testosterone and electroencephalography spectra in developmental male rhesus Macaca mulatta monkeys
679
Serum testosterone is not a correlate of prostate cancer lymph node involvement, but does predict biochemical failure for lymph node positive disease
680
SERUM TESTOSTERONE LEVELS IN NIGERIAN MALE MARIJUANA AND CIGARETTE SMOKERS
681
Serum theophylline and menstrual asthma attack
682
Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease
683
Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection
684
Serum thrombopoietin and platelet antibodies in thrombocytopenic patients with chronic hepatitis C virus: clinical application of platelet indices
685
Serum Thrombopoietin Levels and Its Relationship With Thrombocytopenia in Patients With Cirrhosis
686
Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis
687
Serum thymic stromal lymphopoietin in pediatric atopic patients and its relation to the development of the atopic march
688
Serum thymidine kinase in colorectal neoplasia
689
Serum thyroglobulin measurement: clinical background and main methodological aspects with clinical impact
690
Serum thyroglobulin measurements in differentiated thyroid cancer
691
Serum thyroid hormone concentrations and thyroglobulin autoantibodies in trained and non-trained healthy whippets
692
Serum Thyroid Hormone Levels in Epileptic Children Receiving Anticonvulsive Drugs
693
Serum thyroid hormone profile and trace elements in children receiving valproic acid therapy: A longitudinal and controlled study
694
Serum thyroid hormone, insulin, glucose, triglycerides and protein concentrations in normal horses: Association with topical dexamethasone usage
695
Serum thyroid hormones and performance of offspring in ewes receiving propylthiouracil with or without melatonin
696
Serum thyroxine binding capacity-dependent bias in five free thyroxine immunoassays: assessment with serum dilution experiments and impact on diagnostic performance
697
Serum TIMP-1 Predicts Survival Outcomes of Invasive Breast Carcinoma Patients: A Meta-analysis
698
Serum tissue inhibitor of metalloproteinase-2 (TIMP-2) and matrix metalloproteinase-2 in complex with the inhibitor (MMP-2:TIMP-2) as prognostic markers in bladder cancer
699
Serum tissue inhibitor of metalloproteinases-1 and higher risk features of coronary plaque: A volumetric multivessel intravascular ultrasound study
700
Serum tissue polypeptide-specific antigen is an independent predictor in breast cancer
701
Serum TLR9 and NF-κB Biochemical Markers in Patients with Acute Pancreatitis on Admission
702
Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease
703
Serum TNF-α levels in relation to alcohol consumption and common TNF gene polymorphisms
704
Serum TNF-α, IL-10 and IL-2 in Schizophrenic Patients Before and After Treatment with Risperidone and Clozapine
705
Serum total amylase, pancreatic amylase and lipase activities in epileptic children treated with sodium valproate monotherapy
706
Serum total and fractionated cholesterol distribution and prevalence of hypercholesterolemia in urban and rural communities in Saudi Arabia
707
Serum Total and HDL-Cholesterol in Ischemic and Hemorrhagic Stroke
708
Serum Total Antioxidant Capacity of Epileptic Children before and after Monotherapy with Sodium Valproate, Carbamazepine, and Phenobarbital
709
serum total antioxidant status and oxidative stress marker levels of subjects in a lead-zinc mining community of ebonyi state, nigeria: evidence of lead intoxication
710
Serum Total Antioxidant Status and Oxidative Stress Marker Levels of Subjects in a Lead-Zinc Mining Community of Ebonyi State, Nigeria: Evidence of Lead Intoxication
711
Serum Total Bilirubin Concentration Is Inversely Correlated with Framingham Risk Score in Koreans
712
Serum Total Bilirubin Level, Prevalent Stroke, and Stroke Outcomes: NHANES 1999–2004
713
Serum Total Calcium and Inorganic Phosphate are Higher in Exclusively Breast Fed Infants than Infants on Mixed Diet
714
Serum total cholesterol and mortality in middle-aged Korean women
715
Serum total cholesterol levels and risk of mortality from stroke and coronary heart disease in Japanese: The JACC study
716
Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis
717
Serum total homocysteine concentration and risk of stroke
718
Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: The JACC study
719
Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey
720
Serum total protein, albumin and advanced oxidation protein products (AOPP) - implications in oral squamous cell carcinoma
721
Serum Total Sialic Acid and Lipid Bound Sialic. Acid LevelAmong Patients with Different Sites of Oral Cavity Cancer
722
Serum total sialic acid in cholangiocarcinoma patients: an ROC curve analysis
723
Serum total sialic acid levels as an indicator for the humoral immune status in the chemotherapy-treated and untreated patients with acute lymphoblastic leukemia
724
Serum total sialic acid, lipid peroxidation, and glutathione reductase levels in patients with rheumatoid arthritis
725
Serum trace element levels and the complexity of inter-element relations in patients with Parkinsonʹs disease
726
SERUM TRACE ELEMENTS (ALUMINIUM, COPPER, ZINC) IN HEMODIALYSIS PATIENTS
727
SERUM TRACE ELEMENTS IN CHILDREN ON MAINTENANCE HEMODIALYSIS
728
Serum Trace Elements in Coronary Artery Bypass Graft Surgery: The Relationship Between Trace Element Supplementation and Period of Mechanical Ventilation in a Randomized Double-Blind Placebo-Controlled Trial
729
Serum Trace Elements in Coronary Artery Bypass Graft Surgery: The Relationship Between Trace Element Supplementation and Period of Mechanical Ventilation in a Randomized Double-Blind Placebo-Controlled Trial
730
Serum Transaminases as a Predictor of Response to Combined Interferon and Ribavirin Therapy for Chronic HCV Infection Patients
731
Serum Transferrin Receptor as a Marker of Erythropoiesis Suppression in Patients on Chronic Transfusion
732
Serum Transferrin Receptor Concentrations In Diagnosing And Differentiating Iron Deficiency Anemia From Anemia Of Chronic Diseases In Children
733
Serum transferrin receptor in the evaluation of the iron status in elderly hospitalized patients with anemia
734
Serum Transforming Growth Factor Beta1 in Hepatitis C Virus Related Chronic Liver Disease and Hepatocellular Carcinoma Patients
735
Serum Transforming Growth Factor-beta (TGF-beta),Matrix Metalloproteinase-2 (MMP-2),Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitors of Metalloproteinase (TIMP-1) Levels in Childhood Asthma
736
Serum Triggering Receptor Expressed on Myloid Cells-1 (sTREM-1) and its Role in Diagnosis of Neonatal Sepsis
737
Serum triglyceride level in type 2 diabetes mellitus patients with or without Frozen shoulder
738
Serum Triglyceride Level: A Predictor of Complications and Outcomes in Acute Pancreatitis?
739
Serum triiodothyronine elevation in Israeli combat veterans with posttraumatic stress disorder: A cross-cultural study
740
Serum troponin I as an indicator of myocarditis in lambs affected with foot and mouth disease
741
Serum Troponin I Level for Diagnosis of Acute Coronary Syndrome in Patients with Chronic Kidney Disease
742
Serum Troponin Levels, APACHE II Score and Mortality Rate for Non-Cardiac Reasons in RCU Patients
743
Serum trypsin inhibitory capacity in hemodialysis patients
744
Serum trypsin-inhibitory activity in five species of farmed fish
745
Serum tryptase levels and Kounis syndrome
746
Serum tryptase levels in acute coronary syndromes
747
Serum tumor marker CA19-9 in the follow-up of patients with cystic echinococcosis
748
Serum tumor marker detection on PEGylated lipid membrane using biosensor based on total internal reflection imaging ellipsometry
749
Serum tumor marker immunoassays in gynecologic oncology: Establishment of reference values
750
Serum tumor markers in testicular cancer
751
Serum tumor markers in the management of ovarian, endometrial and cervical cancer
752
Serum tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and IL-17 levels are associated with disease activity in systemic lupus erythematosus patients with and without nephritis
753
Serum Tumor Necrosis Factor-α and Interferon-γ Levels in Pediatric Mycoplasma pneumoniae Pneumonia: A Systematic Review and Meta-Analysis
754
Serum tumour markers: from quality control to total quality management
755
Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women:: The EPIDOS study
756
Serum tyrosine hydroxylase activity is increased in melanoma patients. An ROC curve analysis
757
Serum Tyrosine Level in Acute Murine Toxoplasmosis
758
Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: A three year follow-up study
759
Serum Urea and Creatinine Levels in Nigerian Local Horses Naturally Infected with Babesia
760
Serum urea concentration as a predictor of dietary lysine requirement in selected lines of pigs
761
Serum Urea Predicts Long-term Mortality in Hospitalized Patients with Decompensated Cirrhosis
762
Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
763
Serum uric acid and diabetic nephropathy
764
Serum uric acid and multiple sclerosis
765
Serum uric acid and renal survival prognosis in primary glomerulonephritis patients in a retrospective single- center cohort
766
Serum Uric Acid and Risk of Coronary Heart Disease: Atherosclerosis Risk in Communities (ARIC) Study
767
Serum uric acid and risk of ischemic stroke: The ARIC Study
768
Serum Uric Acid and Salt Sensitivity in the Normotensive Population: An Iranian Sample
769
Serum uric acid as a marker of target organ damage in primary hypertension
770
Serum Uric Acid as a Potential Concomitant with Carotid Atherosclerosis
771
Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease
772
Serum uric acid as an independent predictor of recurrence in ischemic stroke patients
773
Serum Uric Acid Correlation with EchocardiographicIndices in Children with Dilated Cardiomyopathy
774
Serum uric acid in hypertensive patients with and without peripheral arterial disease
775
Serum Uric Acid Is a Determinant of Metabolic Syndrome in a Population-Based Study
776
Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study
777
SERUM URIC ACID IS ASSOCIATED WITH DIETARY AND LIFESTYLE FACTORS IN ELDERLY WOMEN IN SUBURBAN GUANGZHOU IN GUANGDONG PROVINCE OF SOUTH CHINA
778
Serum Uric Acid Level and Diverse Impacts on Regional Arterial Stiffness and Wave Reflection
779
Serum uric acid level and its association with cardiometabolic risk factors in prediabetic subjects
780
Serum Uric Acid Level and Metabolic Syndrome in Patients Undergoing Coronary Angiography
781
Serum uric acid level in acute stroke patients
782
Serum Uric Acid Level in Hypertensive Patients with Acute Myocardial Infarction
783
Serum uric acid level is an independent risk factor for presence of calcium in coronary arteries: an observational case-controlled study
784
Serum Uric Acid Levels and Its Association with Cardiovascular Risk Factors
785
Serum Uric Acid Levels in Different Phases of Acute Severe Manic and Depressed Patients
786
Serum uric acid levels on admission and prognosis of acute coronary syndrome: a bi-institutional report
787
Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients
788
Serum Uric Acid Status and Its Association with Bone Mineral Density in the Elderly People Aged 60 Years and More
789
Serum uric acid, its change with diuretic use and risk of cardiovascular events in the systolic hypertension in the elderly program (SHEP)
790
Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease
791
Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flow
792
Serum Vascular Endothelial Growth Factor (VEGF) levels in patients with alpha thalassemia
793
SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AND CD34 ENDOTHELIAL CELL MARKER IN LYMPHOID MALIGNANCIES
794
Serum vascular endothelial growth factor as a predictor of clinical outcomes in anterior circulation ischemic stroke
795
Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome
796
Serum vascular endothelial growth factor in cyanotic congenital heart disease functionally contributes to endothelial cell kinetics in vitro
797
Serum vascular endothelial growth factor in Iranian patients with moderate-severe psoriasis before and after treatment: a PASI-75 response as a practical treatment goal
798
Serum Vascular Endothelial Growth Factor in Patients with Hepatocellular Carcinoma and its Validity as a Tumor Biomarker
799
Serum Vascular Endothelial Growth Factor Level in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation: Experience of a Single Western Center
800
Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis
801
Serum Vascular Endothelial Growth Factor VEGF and Interlukin-8 As a Novel Biomarkers For Early Detection of Ovarian Tumors
802
Serum vascular endothelial growth factor-receptor 1 during liver regeneration
803
Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis
804
Serum VEGF levels in gastric cancer patients: correlation with clinicopathological parameters
805
Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival
806
Serum VEGF levels in women with a benign breast tumor or breast cancer
807
Serum VEGF levels in women with a benign breast tumor or breast cancer
808
Serum VEGF—As a prognostic factor of atherosclerosis
809
Serum viral markers in Iranian patients with congenital bleeding disorder
810
Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy
811
Serum visfatin in sickle cell disease: association with frequency of vaso-occlusive crises
812
Serum Visfatin Level in Egyptian Diabetics With and Without Microvascular Complications
813
Serum Visfatin Levels Should Be Evaluated with Further Markers of Endothelial Inflammation
814
Serum vitamin A and E, copper, zinc and selenium concentrations and their relationship with health outcomes in dromedary hospitalized camels (Camelus dromedarius)
815
Serum vitamin A and vitamin E concentrations after parenteral vitamin A administration in sheep
816
Serum vitamin A concentration and the risk of hip fracture among women 50 to 74 years old in the United States: A prospective analysis of the NHANES I follow-up study
817
Serum Vitamin A Levels in Patients with Chalazion Mohammad Malekahmadi Fereydoun Farrahi Afshin Tajdini
818
Serum vitamin C concentrations and diabetes: findings from the third National Health and Nutrition Examination Survey, 1988-1994
819
Serum vitamin D and IgE levels in infants and children under 2 years of age with recurrent chest wheeze
820
Serum Vitamin D and Interleukin-6 Levels in Patients with Preeclampsia and Healthy Pregnant Women
821
Serum vitamin D and parathormone (PTH) concentrations as predictors of the development and severity of diabetic retinopathy
822
Serum Vitamin D as a Predictor to the Response of Interferon Therapy in HCV Genotype 4
823
Serum vitamin D concentrations among elderly people in Europe
824
SERUM VITAMIN D CONCENTRATIONS ARE ASSOCIATED WITH FALLING AND COGNITIVE FUNCTION IN OLDER ADULTS
825
Serum Vitamin D Deficiency in NICU Hospitalized Neonates and Its Association with Neonatal Outcomes
826
Serum vitamin D in hypertensive patients versus healthy controls is there an association?
827
Serum vitamin D level – the effect on the clinical course of psoriasis
828
Serum Vitamin D Level and Female Teenage Caries Experience
829
Serum Vitamin D Level and Hypertensive Crises
830
Serum vitamin D level in Egyptian children with atopic dermatitis and efficacy of vitamin D supplementation
831
Serum vitamin D level in patients with newly diagnosed pemphigus vulgaris
832
Serum vitamin D level in patients with viral warts
833
Serum vitamin D levels in girls with central precocious puberty
834
Serum Vitamin D Levels in Premature Neonates with Retinopathy of Prematurity; Prevalence, Severity, and Types of Treatments; A Cross-Sectional Study from Iran, 2019-2020
835
Serum Vitamin D Status in Older Adults: A Cohort Study
836
Serum vitamin D, calcium, and phosphorus concentrations in ponies, horses and foals from the United States and Thailand
837
Serum Vitamin D, Mania and Depression-Related Scores: A Comparison among Mixed Bipolar, Mania, and Healthy Subjects
838
Serum Vitamin D3 Levels in Chronic Lymphocytic Leukemia and Its Relevance with Clinical Prognostic Factors
839
Serum Vitamins, Carotenoids, and Angina Pectoris: Findings from the National Health and Nutrition Examination Survey III
840
Serum xylosyltransferase I activity, the new biochemical fibrosis marker, is not affected by renal insufficiency
841
Serum YKL-40 and assessment of severity of bronchial asthma in Egyptian children
842
Serum YKL-40 as a Biomarker in Egyptian Breast Cancer Females
843
Serum YKL-40 is increased in patients with hepatic fibrosis
844
Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia
845
Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis
846
Serum zinc and copper concentrations in brucellosis patient
847
Serum zinc and copper levels in children with febrile convulsion
848
Serum Zinc and Copper levels in nephrotic syndrome patients
849
Serum zinc and protein levels: Lack of a correlation in hospitalized patients with AIDS
850
Serum zinc and protein status in AIDS patients
851
Serum zinc and serum lipid profiles in 778 adults,
852
Serum Zinc Concentration Could Predict Bone Mineral Density and Protect Osteoporosis in Healthy Men
853
Serum zinc concentrations in children with acute bloody and watery diarrhoea
854
Serum zinc concentrations in patients on maintenance hemodialysis and its relationship with anemia, parathyroid hormone concentrations and pruritus severity
855
Serum zinc level and children's asthma: A systematic and meta-analysis review article
856
Serum zinc level in children presenting with febrile seizures
857
Serum Zinc Level in Children With Febrile Convulsion
858
Serum Zinc Level in Children with Febrile Convulsion and its Comparison with that of Control Group
859
SERUM ZINC LEVEL IN CHILDREN WITH FEBRILE SEIZURE
860
Serum Zinc Level in Children with Febrile Seizure
861
Serum Zinc Level in Children With Simple Febrile Convulsions
862
Serum zinc level in depressed patients during zinc supplementation of imipramine treatment
863
Serum Zinc Level in Dilated and Ischemic Cardiomyopathy
864
Serum zinc level in patients with pneumonia: a six-month long cross-sectional descriptive study at Liaquat University Hospital Hyderabad, Sindh, Pakistan
865
SERUM ZINC LEVEL IN PATIENTS WITH SIMPLE FEBRILE SEIZURE
866
Serum Zinc Level in Recurrent Nephrotic Syndrome
867
Serum Zinc Level in Thalassemia Major
868
Serum zinc levels and goiter in Iranian school children
869
Serum zinc levels and zinc binding capacity in thalassemia
870
Serum Zinc Levels in Children 1 - 59 Months of Age with Pneumonia: A Single-Center Surveillance in India from 2014 to 2016
871
Serum Zinc Levels in Children and Adolescents with Type-1 Diabetes Mellitus
872
Serum zinc levels in demented institutionalized patients
873
Serum zinc levels in hospitalized children with acute lower respiratory infections in the north-central region of Nigeria
874
Serum zinc levels in patients with multiple warts
875
Serum zinc status in thalassemic adolescents attending Yangon Children Hospital, Myanmar
876
SERUM ZINC STATUS, OXIDATIVE STRESS & CHRONIC LOW GRADE INFLAMMATION IN HIGH FAT DIET FED RABBITS.
877
Serum Zinc Values in Adult Patients Undergoing Bone Marrow Transplantation
878
Serum zinc values in children with congenital heart disease
879
Serum zinc, copper, selenium, and lead levels in children with chronic renal failure
880
Serum Zinc: A Noninvasive Biomarker for the Prediction of Invasive Placentation
881
Serum α1-antichymotrypsin level as a marker for Alzheimer-type dementia
882
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status
883
Serum α-globulin fraction in horses is related to changes in the acute phase proteins
884
Serum α-N-acetylgalactosaminidase is associated with diagnosis/prognosis of patients with squamous cell carcinoma of the uterine cervix
885
Serum β2-Microglobulin and Total Sialic Acid levels in Oral Squamous Cell Carcinoma patients: A South Indian Study
886
Serum β2-microglobulin in fetuses with urinary tract anomalies
887
Serum β-Defensin-2 Levels and Their Relationship with the Clinical Course and Prognosis in Patients with Crimean-Congo Hemorrhagic Fever
888
Serum β-glucuronidase activity in a population of ex-coalminers
889
Serum β-glucuronidase activity in a population of ex-coalminers
890
Serum γ-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population
891
Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine
892
Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine
893
Serum/plasma methylmercury determination by isotope dilution gas chromatography-inductively coupled plasma mass spectrometry Original Research Article
894
Serum-based metabolic alterations in patients with papillary thyroid carcinoma unveiled by non-targeted 1H-NMR metabolomics approach
895
Serum‑based microRNA biomarkers for major depression: MiR‑16, miR‑135a, and miR‑1202
896
Serum-Dependent Enhancement of Coxsackievirus B4-Induced Production of IFNα, IL-6 and TNFα by Peripheral Blood Mononuclear Cells
897
Serum-dependent potentiation of lipopolysaccharide-induced nitric oxide production is mediated by the events after the transcription of inducible type of nitric oxide synthase
898
Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes
899
Serum-free cell culture medium induces acceleration of wound healing in guinea-pigs
900
Serum-free cell culture system supplemented with lipid-rich albumin for hepatitis C virus (strain O of genotype 1b) replication
901
Serum-free coculture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells
902
Serum-free culture of rat proximal tubule cells with enhanced function on chitosan
903
Serum-free hybridoma culture: ethical, scientific and safety considerations Original Research Article
904
Serum-free thyroxine and thyrotropin concentrations in euthyroid patients with decompensated congestive heart failure
905
Serum-Glutamic-Pyruvic-Transaminase (SGPT) and Serum- Glutamic-Oxaloacetic-Transaminase (SGOT) Estimation in Different Groups of Women Infected with Toxoplasmosis
906
Serum-Ionized Calcium in Mexican Protein-Energy Malnourished Children
907
Serumleptin, Triglycerides, Cholestrol and Hdl- Cholestrol In Non Dlabetic Obese Subjects
908
Serum-prostatic specific antigen level as a promising marker in infertile women with polycystic ovarian disease
909
Serum-protein effects on the detection of the β-blocker propranolol by ion-transfer voltammetry at a micro-ITIES array
910
Serum-resistance in Haemophilus parasuis is associated with systemic disease in swine
911
Serum-soluble APRIL influences survival in patients with chronic lymphocytic leukemia
912
SerumTrace Elements in Febrile Seizure: A Case-Control Study
913
Servant Leadership and Influence on Changes Management in Schools
914
Servant Leadership and Organizational Trust in Food and Beverage Sector: Sample of Konya-Beyşehir
915
Servant leadership and work engagement: Exploring the mediation role of affective commitment and job satisfaction
916
SERVANT LEADERSHIP IN NON- GOVERNMENTAL ORGANIZATIONS (NGOs)
917
SERVANT LEADERSHIP THROUGH DISTANCE LEARNING: A Case Study
918
Servant leadership to improve innovative work behavior through person organization fit and knowledge sharing behavior as mediation variables at employees of PT Telkom Akses Surabaya Utara, Indonesia
919
SERVANT LEADERSHIP TOWARDS THE 21ST RICH MEDIA TECHNOLOGIES AMIDST COVID-19
920
Serve and Learn: Implementing and Evaluating Service–Learning in Middle and High Schools, D. Brilhart. Lawrence Erlbaum Associates, Mahwah, New Jersey and London (2004). 261pp., ISBN 0-8058-4421-X.
921
Server allocation subject to variance constraints
922
Server based application level authorisation for Rotor
923
Server consolidation for heterogeneous computer clusters using Colored Petri Nets and CPN Tools
924
Server cost minimization in a distributed servers architecture for on-demand video services
925
Server farms with setup costs
926
Server for experimental data from LHD
927
Server unavailability reduces mean waiting time in some batch service queuing systems
928
Server-directed transcoding
929
Service access and service system development in a childrenʹs behavioral health system of care
930
Service Adaptable 3G Turbo Decoder for Indoor, Low Range Outdoor Environment
931
Service aged 69 and 115 kV XLPE cables
932
Service agents and virtial enterprises: A survey
933
Service and capacity allocation in M/G/c/c state-dependent queueing networks
934
Service and cost benefits through clicks-and-mortar integration: Implications for the centralization/decentralization debate
935
Service and education: Forging a partnership
936
Service and Energy Management in Fog Computing: A Taxonomy Approaches and Future Directions
937
Service architecture and content provision. The network provider as editor
938
Service architectures for the wireless world
939
Service Aspects of Industrial Products Lead to Future Product Purchase Intentions
940
Service attributes, customer satisfaction and return usage: A case of Uber Malaysia
941
Service Based Enume ration
942
Service bid comparisons by fuzzy ranking in open railway market timetabling
943
Service branding: consumer verdicts on service brands
944
Service CAD System - Evaluation and Quantification -
945
Service CAD system to integrate product and human activity for total value
946
Service capability and performance of logistics service providers
947
Service capacity decision and incentive compatible cost allocation for reporting usage forecasts
948
Service capacity in vehicular networks: A resource dissemination analysis
949
Service category-to-wavelength selection technique for QoS support in connection-oriented optical packet switching
950
Service center trade-offs between customer impatience and power consumption
951
Service centers location problem considering service diversity within queuing framework
952
Service chain-based business alliance formation in service-oriented architecture
953
Service cock only indirectly affects hatchability in laying hens
954
Service Composition and Customization of Its Features based on Combined Classification
955
Service Composition Management: A Risk-Driven Approach
956
Service Conflict Management Framework for Multi-user Inhabited Smart Home
957
Service consumption criticality in failure recovery
958
Service contracts: A stochastic model
959
Service contracts—An instrument of international logistics supply chain: Under United States and European Union regulatory frameworks
960
Service control point overload rules to protect intelligent network services
961
Service customization: To upgrade or to downgrade? An investigation of how option framing affects tourists’ choice of package-tour services
962
SERVICE DELIVERY AND CUSTOMERS’ SATISFACTION IN SOME SELECTED HOTELS IN IKEJA AREAS OF LAGOS STATE
963
Service delivery comparisons on household connections in Taiwanʹs sewer public–private-partnership (PPP) projects
964
Service delivery for microsystems production: A study
965
Service delivery framework for adolescents with communication problems who are involved in violence
966
Service Delivery System Practices in Malaysian Hotel Operations: An Exploratory Study
967
Service Dependent Ghetto formation—a transferable concept?
968
Service design and operations strategy formulation in multicultural markets
969
Service Development and Implementation of an Exercise Therapy Unit in a Psychiatric Hospital in Iran: A Brief Report
970
Service differentiation and performance of weighted window-based congestion control and packet marking algorithms in ECN networks
971
Service differentiation economic models and analysis of market-based QoS interconnections
972
Service differentiation for delay-sensitive applications: an optimisation-based approach
973
Service differentiation mechanisms for WLANs
974
Service Differentiation of IEEE 802.11e
975
Service differentiation with MEDF scheduling in TCP/IP networks
976
Service discovery 101
977
Service discovery in mobile ad hoc networks: an overall perspective on architectural choices and network layer support issues
978
Service Engineering: a novel engineering discipline for producers to increase value combining service and product
979
Service equality in virtual reference
980
Service failure and consumer switching behaviors: Evidence from the insurance industry
981
Service failure recovery: The moderating impact of individual-level cultural value orientation on perceptions of justice
982
Service Failures and Recovery in Tourism and Hospitality: A Practical Manual
983
Service failures identification: The involvement of the interrelation effect in service practices
984
Service Fairness, Relationship Quality and Customer Loyalty in the Banking Sector of Pakistan
985
Service fatigue cracking in an aircraft bulkhead exposed to a corrosive environment
986
Service for fault tolerance in the Ad Hoc Networks based on Multi Agent Systems
987
Service gap minimization in G/D/1/B+1 queues
988
Service Guarantee Strength: The key to service quality
989
Service hours with asymmetric distributions of ideal service time
990
Service implications from a comparison of the evidence on the effectiveness and a survey of provision in England and Wales of COPD specialist nurse services in the community
991
Service improvement by business process management using customer complaints in financial service industry
992
Service in the Gulf War and Significant Health Problems: Focus on the Central Nervous System
993
Service in the restaurant industry: an American and Irish comparison of service failures and recovery strategies
994
Service index-based fairness scheduling in wireless ad hoc networks
995
Service industries in the world economy : P W Daniels Blackwell, Oxford (1993) 210 pp £11.99 ISBN 0 63117703 5
996
Service industries, globalization, and urban restructuring within the Asia-Pacific: new development trajectories and planning responses
997
Service infusion as agile incrementalism in action
998
Service Innovation and Service Innovation Performance: A Study of Banking Services
999
Service Innovation. Organizational Responses to Technological Opportunities & Market Imperatives;: Joe Tidd and Frank M. Hull (Eds.); Imperial College Press, London, September 2003; 437 pages, ISBN 1-86094-367-5, US$ 65/£ 48
1000
Service innovation: Inward and outward related activities and cooperation mode
